A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED …
conjunction with Ceramic on Ceramic and Taperloc Complete Microplastyarticulation stem in primary total hip arthroplasty compared to patients who received the Exceed ABT Acetabular system with the same combination.
Download A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED …
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
New antibiotic treatment options for uncomplicated ...
clinicaltrials.govtreatment options for gonorrhoea and only a few new drugs in the development pipeline, it is important to test existing antibiotics for their efficacy in gonorrhoea treatment. Objective : This project aims to identify new treatment modalities for uncomplicated gonorrhoea using
Title: A Phase 1, Randomized, Double-Blind, Placebo ...
clinicaltrials.govA Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of TAK-653 in Healthy Subjects Phase 1 TAK-653 Escalating Single and Multiple Dose Study in Healthy Subjects Sponsor: Takeda Development Centre Europe Ltd. 61 Aldwych London, WC2B 4AE United Kingdom
Controlled, Double, Blind, Placebo, Randomized, Double blind, Placebo controlled
Statistical Analysis Plan (SAP) - ClinicalTrials.gov
clinicaltrials.govstatistical analysis. The subsections below will describe analyses in addition to the descriptive statistics. 6.1 Primary outcome The primary analysis will compare intervention groups (water supplementation vs control treatment) on their mean change in fasting plasma glucose between baseline and 12 months using a linear mixed model.
A Phase II, Randomized, Double -blind, Placebo -controlled ...
clinicaltrials.gov• International Conference on Harmonisation, E6 Good Clinical Practice: Consolidated Guideline. • All applicable laws and regulations, including, without limitation, data privacy laws and regulations. • Regulatory requirements for reporting serious …
Clinical study protocol template - ClinicalTrials.gov
clinicaltrials.govATC anatomical therapeutic chemical ATS/ERS American Thoracic Society/European Respiratory Society AV atrioventricular BMI body mass index BTPS body temperature and pressure saturated BUN blood urea nitrogen CFR Code of Federal Regulations CK creatine kinase CK-MB creatine kinase isoenzyme MB
Chemical, Therapeutic, Anatomical, Anatomical therapeutic chemical
Clinical Study Report (CSR) Template (Drug and Device)
clinicaltrials.govATC Anatomical Therapeutic Chemical CFB change from baseline DHA dapsone hydroxylamine eCRF electronic case report form IGA Investigator’s Global Assessment MedDRA Medication Dictionary for Regulatory Activities mITT modified intent-to-treat NAD N-acetyl dapsone PK pharmacokinetic ...
Chemical, Therapeutic, Anatomical, Anatomical therapeutic chemical
Research Proposal - ClinicalTrials.gov
clinicaltrials.govas fecal microbiota transplantation (FMT). 4. Procedures Tissue samples will be obtained from consenting patients at (SDMCUT), or other relevant facilities (see section 6.i below), in accordance with protocols approved by the University of Texas Institutional Review Board (UTIRB). Patients who meet eligibility criteria will have their
Research, Proposal, Fecal, Microbiota, Transplantation, Research proposals, Fecal microbiota transplantation
Novartis CSR template
clinicaltrials.gov9.1 Study design Figure 9-1 Study design BID: twice a day, QD: once a day. This was a multicenter, randomized, double-masked, two-arm, placebo-controlled, parallel-group study in patients with normal tension glaucoma who were insufficiently controlled on travoprost 0.004% (Travatan) monotherapy. Approximately 200 patients were planned to be
DETAILED STATISTICAL ANALYSIS PLAN (SAP)
clinicaltrials.govStatistical principles : 4.1. Multiplicity : The diagnostic and prognostic basic stud y and each sub -study consist of one primary outcome and one or more secondary, exploratory outcomes. We will encounter multiplicity issues due to the multiple
Title: TWILIGHT Study - Ticagrelor With Aspirin or Alone ...
clinicaltrials.govPrior stroke Dialysis-dependent renal failure Active bleeding or extreme-risk for major bleeding (e.g. acute ... Life expectancy < 1 year ... 7.3.4 Adverse Events based on signs and symptoms ...
Related documents
singles.pd Sendd Web - shareholder
files.shareholder.comfranchises in our Knee and Hip categories, we now bring a stronger presence in the faster-growing markets of Sports Medicine, Extremities, Trauma, Foot & Ankle and Dental solutions. ... Modular Femoral Revision System and the Taperloc ® Complete Microplasty Stem.
Zimmer Biomet Holdings, Inc. 1st Quarter 2018 Earnings ...
investor.zimmerbiomet.com• Positive growth of Taperloc ® Complete Hip System and G7® Acetabular System • Sales of Arcos ® Modular Femoral Revision System continued growth • Warsaw North Campus supply constraints linger, but steadily improving
Zimmer Biomet Holdings, Inc. 4th Quarter 2017 Earnings ...
investor.zimmerbiomet.com• Improved sales of the Taperloc ® Complete Hip System and G7 ® Acetabular System • Sales of Arcos ® Modular Femoral Revision System also improved • Warsaw North Campus supply constraints continued to impact growth
IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN ...
www.aboutlawsuits.comHip System that was practical, feasible, and otherwise a reasonable alternative design or formulation that would have prevented or substantially reduced the risk of harm without
ReCap Product Rationale - Biomet UK
www.biomet.co.ukReCap Product Rationale . A complete resurfacing system designed on sound engineering principles, tried and tested materials and clinically proven fixation methods. ... implants such as the Bimetric Hip System, Taperloc Hip System. Hydroxyapatite increases the amount of in growth
Product, System, Complete, Rationale, Recaps, Hip system, Taperloc, Recap product rationale, Taperloc hip system
Taperloc Complete Hip System - Biomet UK
www.biomet.co.ukClinical Success of the Taperloc Hip System 100% Survivorship at a minimum 5 year follow-up in 49 rheumatoid patients2 100% Survivorship at a 2–11 year follow-up in 114 patients 80 years old
System, Complete, Taperloc, Taperloc complete hip system, Taperloc hip system
Bi-Metric Total Hip System - Biomet
www.biomet.fiTaperloc,™ Mallory-Head, ... i-Metric Total Hip System A Member of the Alliance Family¤ P P he Bi-Metric Total Hip System, since its introduction, continues to provide a high degree of versatility and unsurpassed clinical performance. After a 5 to 13 year follow-up on
System, Total, Metrics, Bi metric total hip system, Taperloc, Metric total hip system
MAY 2 22012 Page 1 of 2 SUMMARY El - Consensus Orthopedics
www.consensusortho.comMAY 2 22012 Page 1 of 2 2. 5 10(k) SUMMARY ... The TaperSetTM Hip System is designed for total or partial hip arthroplasty and is intended to be ... previously cleared by FDA under KIO01086 for the Biomet Taperloc Complete Hip System. The
System, Complete, Pages, 12202, Hip system, Taperloc, Taperloc complete hip system, May 2 22012 page 1 of
100 - Consensus Orthopedics
www.consensusortho.comTaperloc Complete Hip System extension. The subject Consensus stemns are still compatible with previously cleared Co~r heads, zirconia and Biolox delta ceramic heads, unipolar heads,
Merge OrthoTemplates V. 39
www.merge.comTaperloc Complete Hip System Full Length XR 123° Femoral Component Reduced Distal, Type 1 Tapers Taperloc Complete Hip System Full Length XR 123° Femoral Component, Type 1 Tapers Taperloc Complete Hip System, 12/14 Tapers, High Offset